University of Maryland Medical Center Burns
The American Diabetes Association 2024 guidelines recommend GLP-1 receptor agonists with proven cardiovascular benefit (liraglutide, dulaglutide, injectable semaglutide) as preferred agents in patients with type 2 diabetes and atherosclerotic cardiovascular disease
Themen wie emotionale Stagnation, unterdrckte Konflikte, Festhalten an Strukturen ohne Bewegung knnen mitschwingen
Weight regain after stopping is real, documented in the STEP 4 trial, and expected when the biology of obesity isn't also addressed
How It Works During your Weight Loss Consultation, the Better Med Spa team takes a detailed history, reviews prior weight loss attempts, screens for contraindications (such as certain thyroid cancers, MEN-2, pancreatitis history, or uncontrolled GI disease), and checks BMI and obesity-related risk factors
These records should be evaluated together